Suboptimal guideline-directed medical therapy and prognosis in patients with heart failure and reduced ejection fraction: The SMYRNA Study

Back

ESC Professional Premium Access

Suboptimal guideline-directed medical therapy and prognosis in patients with heart failure and reduced ejection fraction: The SMYRNA Study

Session: Insights from national studies

Topic: Epidemiology, Prognosis, Outcome

Speaker: Associate Professor U. Sinan (Istanbul, TR)

Event: ESC Congress 2023

Congress Presentation

About the speaker

Associate Professor Umit Yasar Sinan

Istanbul University-Cerrahpasa Institute of Cardiology, Istanbul (Türkiye)

3 presentations

1 follower

6 more presentations in this session

Quality of care and long-term outcomes for patients admitted with heart failure across the pandemic. A nationwide study.

Speaker: Doctor A. Cannata (London, GB)

Incidence of heart failure in patients with coronary heart disease and stroke in a large Chinese cohort study

Speaker: Ms X. LIU (Beijing, CN)

Heart failure early post-discharge appointment: a 1.5-year single-centre experience

Speaker: Doctor I. Fialho (Lisbon, PT)

Multicentre observational registry of patients hospitalized for heart failure and real-life adherence to international guidelines (REAL-HF): first two years (2020-2021) experience.

Speaker: Doctor G. Sanna (Pavia, IT)

Ten year evolution of clinical characteristics and short-term outcome of patients admitted with heart failure

Speaker: Doctor D. Borsboom (Gent, BE)

Access the full session

Insights from national studies

Speakers: Associate Professor U. Sinan, Doctor A. Cannata, Ms X. LIU, Doctor I. Fialho, Doctor G. Sanna...

Access

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources